ArticleOncotarget2017
The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review.
Shi-Long Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it